[Diagnostic value of bilateral inferior petrosal sinus sampling in various modifications and methods of radiation and radionuclide imaging in the diagnosis and differential diagnosis of ACTH-dependent endogenous hypercortisolism].

AIM: To analyze the diagnostic performance of bilateral inferior petrosal sinus sampling (BIPSS) with desmopressin as a stimulation agent and prolactin measurements to control catheter position with or without the ACTH/prolactin normalized ratio calculation in the differential diagnosis of ACTH-dependent endogenous hypercortisolism, and the diagnostics performance of ectopic ACTH-syndrome (EAS) visualization. MATERIALS AND METHODS: A single-center diagnostic study with a retrospective analysis of the data was carried out. The study included patients with ACTH-dependent endogenous hypercorticism with no visualization of pituitary adenoma on MRI or adenoma sizes less than 6 mm. All patients underwent BIPSS with and without calculation of the ACTH/prolactin normalized ratio. Visualization of an EAS included pituitary MRI (to exclude EAS), whole-body CT scan with contrast, and somatostatin receptor scintigraphy with 99mTc-Tectrotide and CT (99mTc-Tectrotide SPECT). The final verification was based on immunohistochemical confirmation of the tumor or stable remission of Cushing's disease (CD) after surgical treatment. Statistical data processing was carried out by using IBM SPSS Statistics 23. Confidence intervals were calculated using the JavaStat online calculator. RESULTS: 230 BIPSS were performed in 228 patients (166 women, 62 men), of which 178 patients were verified as CD and 50 cases were EAS of various localization. The effectiveness of catheterization of petrosal sinuses was 96.9%. The sensitivity of BIPSS without ACTH/prolactin ratio calculation (n=70) was 95.9% (95% CI 86.3-98.9), specificity was 92% (95% CI 75.0-97.8), for the BIPSS with additional determination of ACTH/prolactin-normalized ratio (n=51) - 97.3% (95% CI 86.2-99.5) and 93.8% (95% CI 71.7-98.9), respectively. The use of the MRI method for this sample of patients had a sensitivity of 60.2% (95% CI 52.6-67.5), specificity of 59.2% (95% CI 44.2-73.0), the total body CT with contrast has a sensitivity of 74% (95% CI 59.7-85.4), specificity of 100% (95% CI 97.95-100). The diagnostic accuracy for 99mTc-Tectrotide SPECT in NET visualization has a sensitivity of 73.3% (95% CI 44.9-92.2), specificity of 100% (95% CI 95.3-100). CONCLUSION: BIPSS with desmopressin stimulation and prolactin measurements to control catheter position, as well as the additional calculation of the ACTH/prolactin-normalized ratio, is an optimal method for the differential diagnosis of EAS. Patients who are identified an EAS on BIPSS may be further referred for 99mTc-Tectrotide SPECT and CT for tumor visualization.

[Drug therapy for acromegaly].

Acromegaly is a severe disease caused by excessive secretion of growth hormone (GH), usually a pituitary tumor (98%), which in turn leads to a significant increase in the production of insulin-like growth factor 1 (IGF-1) by the liver, which mainly determines the tissue effect of GH.The larger the size of the tumor, the more it produces GH and the less likely it is to achieve adequate control of hormonal secretion. Large tumors that extend beyond the sella turcica are found in 70-80% of patients with acromegaly and present the greatest difficulties for successful treatment.Increased secretion of GH and IGF-1 gives adverse systemic, metabolic and, possibly, neoplastic effects, which reduces the life expectancy of patients with acromegaly and increases the mortality rate by 2-3 times.

[Dehydroepiandrosterone: physiological role and possibilities of use as a drug].

Dehydroepiandrosterone (DHEA) is one of the important androgens synthesized by the adrenal cortex from 17-hydroxypregnenolone. In the mesh zone of the adrenal cortex, with the participation of enzymes 17, 20-desmolase and 17-a-hydroxylase, the cholesterol is sequentially converted through 17-hydroxypregnenolone (17-OH-pregnenolone) to DHEA. It has been proven that the adrenal glands are mainly involved in the synthesis of DHEA (70%) and its less active metabolite, dehydroepiandrosterone sulfate (DHEA-S) (85%). Only 10% DHEA is synthesized in the gonads. There is evidence of the formation of DHEA in the central nervous system, where enzyme systems (P450c17) are detected in astrocytes and neurons that synthesize DHEA from pregnenolone.